Exenatide Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Also known as: BYETTA, BYDUREON/BYDUREON BCise

Pipeline

Phase 4: 1

Top Sponsors

Maisa N. Feghali, MD1
AstraZeneca1

Indications

Diabetes2
Gestational Diabetes1
Pancreatic Cancer1
Cancer1

Other1 trial

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Pittsburgh, Pennsylvania1 trial

Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Magee Womens Hospital of UPMC

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.